Lung cysts in pulmonary alveolar proteinosis.

M. Kokosi (London, United Kingdom), P. Saunders (London, United Kingdom), P. Molyneaux (London, United Kingdom), P. George (London, United Kingdom), G. Margaritopoulos (London, United Kingdom), V. Kouranos (London, United Kingdom), T. Pickworth (London, United Kingdom), F. Chua (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom), C. Morgan (London, United Kingdom)

Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Disease area: Interstitial lung diseases

Congress or journal article abstract

Abstract

Background

Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by deposition of abnormal PAS positive lipoproteinaceous material in the alveolar spaces due to defective surfactant clearance by alveolar macrophages.  It is associated with alterations in the immune state and secondary chest infections. The radiological pattern of ‘crazy paving’ is thought to be quite characteristic of the disorder. Whole lung lavage (WLL) is the treatment of choice with increasing support for inhaled GMCSF.

Aims/Methods

To describe three cases of PAP with concomitant lung cysts and their potential implications in management.

Results

Three patients, 19, 22 and 26 year old, with autoimmune PAP and acute presentation with severe respiratory failure and typical ‘crazy paving’ demonstrated single lung cysts on imaging. Two of them grew Mycobacterium intracellulare but they were not considered to have active NTM infection.

The first patient, with a left upper lobe cyst, underwent right whole lung lavage (WLL) and fiberoptic segmental lavage of the lingula and left lower lobe with excellent response. The second patient, with a right upper lobe cyst, had uneventful bilateral WLL with subsequent reduction of the size of the cyst. The third patient presented with a right lower lobe cyst. WLL was delayed and inhaled GMCSF was initiated without success. Bilateral WLL was performed after resolution of the cyst following treatment with broad spectrum antibiotics.

Conclusion

Lung cysts in PAP are a rare phenomenon and can be associated with secondary infections or potentially fragility and destruction of the alveolar walls in more severe PAP cases. Their presence can have an impact on the patients’ management and choice of treatment.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kokosi (London, United Kingdom), P. Saunders (London, United Kingdom), P. Molyneaux (London, United Kingdom), P. George (London, United Kingdom), G. Margaritopoulos (London, United Kingdom), V. Kouranos (London, United Kingdom), T. Pickworth (London, United Kingdom), F. Chua (London, United Kingdom), T. Maher (London, United Kingdom), E. Renzoni (London, United Kingdom), A. Wells (London, United Kingdom), C. Morgan (London, United Kingdom). Lung cysts in pulmonary alveolar proteinosis.. 3019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009

Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011



Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017

Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004


Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Year: 2020



Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Pulmonary alveolar proteinosis: report of two cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Pulmonary alveolar proteinosis and GM/CSF antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005

Pulmonary alveolar microlithiasis
Source: Eur Respir Rev, 29 (158) 200024; 10.1183/16000617.0024-2020
Year: 2020



Pulmonary alveolar microlithiasis
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Pulmonary alveolar proteinosis, study of 29 cases
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004



Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002

Alveolar proteinosis
Source: Annual Congress 2004 - Update on rare diffuse lung diseases
Year: 2004

Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004